2 completed, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Chenodeoxycholic Acid: new trials by email Literature Review of Chenodeoxycholic Acid trials Research Report on Chenodeoxycholic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5 Xenbilox, Resveratrol, Tahor - Spastic Paraplegia, Hereditary | Phase 2 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 12 | 2015-01-08 | 2025-09-02 |
| Cheno Effect on Transit in Health and IBS-C Sodium chenodeoxycholate (NaCDC), Placebo - Constipation-predominant Irritable Bowel Syndrome | Phase 2 | Completed | Mayo Clinic | 36 | 2009-04-01 | 2012-07-02 |
| Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis chenodeoxycholic acid, lovastatin - Cerebrotendinous Xanthomatosis | Phase 2 | Unknown | National Center for Research Resources (NCRR) | 5 | 1996-01-01 | 2005-06-24 |
Constipation (1) · Ichthyosis Bullosa of Siemens (1) · Metabolism, Inborn Errors (1) · Paraplegia (1) · Rare Diseases (1) · Spastic Paraplegia, Hereditary (1) · Xanthomatosis, Cerebrotendinous (1)
Institut National de la Santé Et de la Recherche Médicale, France (1) · Mayo Clinic (1) · National Center for Research Resources (NCRR) (1)
United States (2) · France (1)
Michael L. Camilleri, M.D. (1) · William Connor (1)
1RC1DK086182 (1), R01DK054681 (1), R01DK079866 (1), UL1RR024150 (1)